Aim of this prospective randomized study was to evaluate whether a diet with meal replacements can be as effective as a conventional energy-restricted modified diet on weight loss, body composition and cardiometabolic risk profile in overweight women. Moreover, the impact of these two different weight management strategies was observed on cardiometabolic risk profile after a self-directed weight stabilization phase following the weight loss phase. After that, the effect of a specific micronutrient composition with omega-3 fatty acids versus placebo on cardiometabolic risk was observed during a following phase of weight loss maintenance.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Weight loss (phase 1)
Timeframe: 3-month dietary intervention (from baseline I to 3rd month)
Total antioxidant capacity (phase 3)
Timeframe: 6-month dietary intervention (from baseline II to 12th month)
Fasting plasma cortisol concentration (phase 3)
Timeframe: 6-month dietary intervention (from baseline II to 12th month)